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Abstract
Background: We aimed to evaluate the risk factors in preschool children admitted to inpatient services with a
diagnosis of recurrent attacks of wheezing.
Method: The medical files of 44 preschool children with 2 or more recurrent hospitalizations resulting from
wheezing between November 2011 and January 2012 were retrospectively investigated.
Results: There were 28 males (64 %) and 16 females. The median age was 14 months (2.0–50). The median
numbers of previous wheezing attacks and hospitalizations were 4 (2–10) and 2 (2–8), respectively. Fourteen
patients (32 %) had been treated for gastroesophageal reflux (GER). The previous and recent hospital evaluations
were investigated. Bronchopulmonary dysplasia and anemia were significantly more common in patients with 3 or
more hospitalizations for wheezing than in those with 2 hospitalizations (p = 0.010 and p < 0.001, respectively).
A review of the cases with 3 or more hospitalizations revealed that a history of GER and anemia were significant
risk factors.
Conclusion: Anemia and GER are risk factors for recurrent hospitalizations resulting from wheezing and should be
treated. If the history and physical examination suggest asthma, inhaler therapy treatment should be administered,
with other investigations planned for patients who do not respond to treatment as expected.
Background
Recurrent wheezing attacks occurring during the pre-
school period represent a significant healthcare con-
cern and comprise one of the most common causes
of emergency department visits and hospitalizations.
The Children’s Respiratory Study (CRS) in Tucson re-
ported a wheezing prevalence of 32 % during the first
year of life, which decreased to 17.3 % at 2 years of
age and to 12 % at 3 years of age [1]. One in three
children experience at least one acute wheezing attack
before the age of three years [2].
Recurrent wheezing impairs the quality of life for the
patient and his/her family and causes a significant eco-
nomic burden resulting from the healthcare expenses as-
sociated with the condition [3–5]. A phone call-based
study by Bisgaard et al. detected the prevalence of recur-
rent wheezing among children between 1 and 5 years of
age as 27 %, 29 % and 48 % in America, Northern Europe
and Southern Europe, respectively. The rate of presenta-
tion to emergency departments and hospitalization was
reported to be 16 % and 12 %, respectively, within the last
6 months [6].
A multinational study conducted in 17 centers in
Latin America and Europe reported a wheezing ratio
of 45.2 % and a recurrent wheezing prevalence of
20.3 % during the first year of life. The same study
reported a rate of emergency department visits for
wheezing of 71.1 % and a rate of hospitalization for
recurrent wheezing of 26.8 % [7].
Whereas the most common cause of recurrent
wheezing is asthma in all age groups, gastroesophageal
reflux disease (GER), foreign body aspiration, broncho-
pulmonary dysplasia (BPD), bronchiolitis obliterans, an
immunodeficiency, primary ciliary dyskinesia, vocal
cord dysfunction, cardiac etiologies and structural
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abnormalities should be considered in the differential
diagnosis [8]. A definitive diagnosis is based on invasive
investigations such as radiological studies, laboratory
values and bronchoscopy as well as the clinical history
and physical examination. Because of the lack of con-
sensus on the treatment for recurrent wheezing, many
investigations could be conducted, and various treat-
ments could be administered.
We evaluated the medical records of preschool chil-
dren with a history of at least two hospitalizations
resulting from attacks of wheezing.
Methods
The medical files of 44 children with two or more re-
current hospitalizations resulting from wheezing were
retrospectively examined. The study was conducted in
the Pediatric Inpatient Service at Sisli Hamidiye Etfal
Training and Research Hospital between November
2011 and January 2012. We included children be-
tween 1 month and 5 years of age with complete re-
cords of at least 2 hospitalizations for wheezing.
Children younger than 1 month and older than 5
years of age and those with incomplete or missing re-
cords were excluded. The demographics, previously
requested investigations and current hospitalization
records were investigated, as were the treatment ap-
proaches. The ethics committee of the hospital
granted approval for the study.
Investigations
In patients with recurrent hospitalizations for wheezing,
laboratory tests, imaging studies and, in some cases,
bronchoscopy, were performed to aid the differential
diagnosis. Detailed explanations of each of the tests per-
formed in this study follow.
Blood tests
A hemogram, the total IgE values, specific IgE-inhalant
allergens, specific IgE-food mixtures, and serum im-
munoglobulin count were obtained. For specific IgE-
inhalant allergens, tree pollens, betula berrucosa,
meadow pollens, weed pollens, house dust, dermato-
phagoides pteronyssinus, dermatophagoides farinae,
fungi, yeast, mold and animal epithelia were investi-
gated. For food mixtures, egg white, milk, fish (gadi-
formes), flour, peanut and soybeans were investigated.
Anemia is defined as a hemoglobin level of less than
the 5th percentile for age. The serum total IgE levels
were determined to be normal or high based on the
participants’ ages. Eosinophilia refers to an absolute
eosinophil count in the peripheral blood of ≥ 500 eo-
sinophils/microL/Specific IgE inhalant allergens and
food allergens were determined to be normal or high,
based on the reference values.
Radiological investigations
Chest radiography and, in selected patients, computed
thoracic tomography were performed. The investigation
results were assessed by a radiologist.
Purified protein derivative skin test
Purified protein derivative (PPD) skin testing was per-
formed in the patients with a history of tuberculosis
contact. The PPD solution was obtained from the Tu-
berculosis Dispensary in prefilled injectors and injected
under appropriate conditions into the forearm of the
patients via an intradermal route; the diameter of the
induration occurring after 72 h was measured. For the
patients without risk factors, an induration ≥ 15 mm
was considered positive.
Sweat test
The sweat test was performed using the quantitative
pilocarpine iontophoresis method in accordance with
the international standards.
Esophageal pH monitoring
The patients underwent 24-h lower esophageal pH mon-
itoring for longer than 18 h (ComforTec Plus Single Use
Ph Prob, Sandhill Scientific, ZEPHR, USA). If the patient
were receiving anti-reflux treatment, the drugs were
discontinued 7 days before the investigation. The esopha-
geal pH monitoring test results were considered to be ab-
normal when the time of pH ≤ 4.0 was greater than 6 % of
the duration of the pH monitoring study for children over
1 year old and greater than 10 % for children younger than
1 year of age.
Echocardiography
Echocardiography (ECHO) was performed to assess the
internal structure and functions of the heart via sound
waves. A pediatric cardiologist assessed the results.
Chest computed tomography
Chest computed tomography (CT) was performed in se-
lected patients to provide a detailed anatomy of the
mediastinum, large airways, and lung parenchyma.
Flexible fiberoptic bronchoscopy
This investigation was performed by a pediatric pulmo-
nologist under general operation room conditions using
general or local anesthesia.
Statistical analysis
The descriptive properties of the variables were detected
(the mean, median and frequency). The compliance of
the variables with the normal distribution was checked.
The Student’s t-test was used for the comparison of the
variables with normal distribution. A comparison of the
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categorical variables was made using the chi-square test.
Chi square testing (with the Fisher exact test where indi-
cated by low expected cell counts) was used for this pur-
pose. A univariate analysis was performed in the logistic
regression analyses. The variables, which were p < 0.250
and considered potentially clinically significant, were in-
cluded in the multivariate analysis, and a multiple logis-
tic regression analysis was performed; p < 0.05 was
considered significant. The Statistical Package for Social
Sciences (SPSS) software, v. 17, (Chicago, USA) was used
to evaluate the results.
Results
A total of 52 patients aged 1 month to 5 years with at least
2 recurrent hospitalizations resulting from wheezing were
admitted during the study period. A total of 44 patients
(16 females, 28 males) with complete medical records
were enrolled in this study. The clinical characteristics of
the patients are presented in Table 1. The median age was
14 months (2.0–50). Two patients (5 %) were below the
3rd percentile for height and weight. The median number
of previous wheezing attacks and hospitalizations were 4
(2–10) and 2 [2–8], respectively. Eight of the patients were
born prematurely (18 %), 14 (32 %) were admitted to the
NICU, 7 (16 %) were intubated and 5 (11 %) were
diagnosed with BPD. Fifteen patients (34 %) were breast-
fed for less than 6 months, and 25 patients (57 %) were
bottle-fed at night. Fourteen patients (32 %) had been
treated for GER. Twenty-one patients (48 %) had a parent
or sibling with a history of asthma, allergic rhinitis or ec-
zema, and 29 patients (66 %) had been exposed to smoke.
The median number of people living in the same house as
the patient was 4 (3–12). A review of the treatment regi-
mens revealed that 9 patients (21 %) were treatment-naïve
(with nebules), and only 10 had received nebule treatment.
Fifteen patients used salbutamol syrup as prescribed.
The previous and recent hospital evaluations were in-
vestigated. The laboratory results are summarized in
Table 2. Based on the hemograms obtained during the
most recent hospitalization, 15 patients (34 %) were
anemic, and 6 (14 %) had eosinophilia. Pulmonary radi-
ography had been performed in all of the patients, and
23 (52 %) patients had infiltration/atelectasis. Immuno-
globulins, including IgA, IgG and IgM were obtained in
38 (86 %) of the patients, and the levels were reported to
be within the normal limits by age. Esophageal pH mon-
itoring had been performed in 10 (23 %) patients, and 5
patients (50 %) were reported to have reflux. Two of the
30 patients who underwent echocardiography (7 %) were
reported to have abnormal results. The immunoglobulin
E level had been obtained in 39 (88 %) patients, 21(53 %)
of whom had a high immunoglobulin E level. The inhalant
panel was obtained for 31 patients and found to be posi-
tive for 3 patients (10 %). A PPD test was applied in 17 pa-
tients (39 %) with a positive tuberculosis contact history,
and the results were negative. Ten patients (23 %) had
undergone a sweat test, and the results for these patients
were normal. Five of the patients undergoing chest CT
Table 1 Clinical characteristics of patients, illustrating risk factors
for recurrent wheezing
Median Range








living in the same house
4 3–12
n %
Sex (males) 28 64
Height and weight <3 % 2 5
Birth history Prematurity 8 18
BPD* 5 11
NICU admission+ 14 32
History of intubation 7 16
Breastfeeding <6 months 15 34
Nocturnal feeding 25 57
GER history 14 32
Inhaler use Regular 10 23
naive 9 21
Salbutamol syrup 15 34
Smoking exposure 29 66
Parental asthma/AR/eczema 21 48
*Bronchopulmonary dysplasia, +Neonatal intensive care unit
Table 2 Summary of the results of investigations performed
Test Subjects tested (%) Abnormal results (%)
Hemogram 44/44 (100) 15/44 (34)–anemia
Eosinophilia 44/44 (100) 6/44 (14)
CXR 44/44 (100) 23/44 (52)–infiltration/atelectasis
IgA, IgG, IgM 38/44 (86) 0/38 (0)–below normal
IgE 39/44 (88) 21/39 (53)–high
Esophageal pH
monitoring




31/44 (70) 3/31 (10)–positive
ECHO 30/44 (68) 2/30 (7)–abnormal
ppd 17/44 (38) 0/17 (0)–positive
Sweat test 10/44 (22) 0/10 (0)–positive
Chest CT 5/44 (11) 5/5 (100)–infiltration
FOB 3/44 (7) 3/3 (100)–increased secretions
CXR Chest X ray, Ig Immunglobulin, ECHO Echocardiography, ppd Purified
protein derivative skin test, CT Computerized tomography, FOB Flexible
fiberoptic bronchoscopy
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(11 %) were reported to have infiltration. Three patients
(7 %) had permanent wheezing and were non-responsive
to nebule treatment; these patients underwent bronchos-
copy, and no pathology, other than increased secretion,
was reported.
The patients were divided into 2 groups as patients
with 2 and patients with 3 or more hospitalizations. The
risk factors and investigation results were compared
(Table 3). The patients with 3 or more hospitalizations
resulting from wheezing had a statistically significantly
higher rate of BPD and anemia relative to the other
group (p = 0.01 and p < 0.001, respectively).
Table 4 reveals the risk factors of the patients with 3
or more hospitalizations. The multivariate regression
analysis revealed that the odds ratio for hospitalization
resulting from a history of GER and the presence of
anemia is 6.29 and 17.03, respectively.
Discussion
Because of the lack of consensus on the description, as-
sessment and treatment of recurrent wheezing in young
children, these cases are quite difficult for clinicians to
manage. Many unnecessary investigations are conducted,
and inadequate treatment is provided. We investigated
the demographics, the requested investigations, and the
results for pre-school children with recurrent hospitali-
zations resulting from wheezing. A comparison of the
patients with 2 and the patients with 3 or more hospital-
izations resulting from wheezing revealed that the pa-
tients with 3 or more hospitalizations had a statistically
significantly higher rate of BPD and anemia relative to
the other group. The regression analysis revealed that a
GER history and presence of anemia were significant risk
factors in patients with 3 or more hospitalizations result-
ing from wheezing.
Several studies have reported that boys have an in-
creased risk of early persistent wheezing and allergic
sensitization [9, 10]. In our study, 64 % of the patients
with recurrent wheezing attacks were boys.
Breastfeeding protects against respiratory infections
during the early period of life. However, the relationship
between breastfeeding and wheezing has not been eluci-
dated [11]. Whereas there are clinical studies suggesting
that breastfeeding is protective against wheezing, other
studies have not detected an association. We failed to
detect an association between breastfeeding and recur-
rent wheezing, although 34 % of the patients were
breastfed for less than 6 months, which is most likely be-
cause of the small sample size.
Passive smoking has a strong correlation with respira-
tory complaints [12]. In this study, we detected a rate of
passive smoking as high as 66 %; however, we failed to
show passive smoking as a risk factor in patients with 3
or more hospitalizations resulting from wheezing. In the
British Cohort Study, a strong correlation was demon-
strated between maternal smoking and the presence of
wheezing during early childhood; however, such a correl-
ation could not be shown for the subsequent period
[13]. The Tucson CRS study suggested that maternal
prenatal smoking affects in utero lung function and in-
creases the risk of wheezing during the first 3 years of
life [14]. A recent mother and child cohort study in
Norway reported that smoking by the grandmother
while pregnant with the mother increases the risk of
asthma in the grandchild, independent of the maternal
smoking status [15]. In this study, we did not investigate
the history of smoking during pregnancy.
A review of the cases with 3 or more hospitalizations
for wheezing revealed that the presence of anemia
Table 3 Comparison of the patients with 2 and patients with 3
or more hospitalizations due to recurrent wheezing attacks
2 3 or more
n: 24 n: 20
n (%) n (%) p
Gender (male) 14 (58) 15 (%75) *0.34
Age(months), mean 19.7 ± 14.3 17.0 ± 10.6 ^0.48
History of NICUa admission 5 (21) 9 (45) *0.16
History of intubation 2 (8) 5 (25) *0.13
BPDb 0 (0) 5 (25) *0.01**
GERc 5 (21) 9 (45) *0.16
Preterm delivery 3 (13) 5 (25) *0.29
Nocturnal feeding 14 (58) 11 (55) *1.00
Nocturnal feeding 14 (58) 11 (55) *1.00
Pathologic pH monitoring 2 (8) 3 (15) *0.34
IgE level (high) 10 (42) 8 (40) *0.57
Abnormal CXRd 13 (54) 10 (50) *1.00
Abnormal Chest CTe 1 (4) 4 (20) *0.16
Positive inhalant/food panel 1 (4) 2 (10) *0.77
Eosinophilia 3 (13) 3 (15) *1.00
Anemia 3 (13) 12 (60) * < 0.00**
Parenteral asthma/eczema/ARf 8 (33) 5 (25) *0.78
ICSg use 16 (67) 14 (70) *1.00
Exposure to smoking 15 (63) 14 (70) *0.83
Neonatal intensive care unita , Bronchopulmonary dysplasia
b,
Gastroesophageal refluxc , Chest Xrayd, Computed tomographye, Allergic
rhinitisf, Inhaler corticosteroid’g
^Results expressed as mean ± SD (student’s t-test). Chi-square test or Fisher’s
exact test. **Statistically significant
Table 4 Multivariate logistic regression analysis showing the risk
factors for 3 or more hospitalization for wheezing attacks
Adjusted OR CI 95 % p
Anemia 17.02 3.03–95.44 0.00
GER 6.28 1.99–33.33 0.03
CI Confidence interval, OR Odds ratio, GER Gastroesophageal reflux
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increased the risk of hospitalization 17.02 fold. The stud-
ies investigating the association between anemia and
lower respiratory infections are limited. Iron deficiency
anemia affects the immune response and alters the me-
tabolism of pathogens. A low tissue hemoglobin level
impairs tissue oxygenation and represents a risk for
lower respiratory infections in children [16]. The litera-
ture data suggest that the presence of anemia increases
the risk of acute lower respiratory infection 3 to 6 fold
[16, 17]. In a randomized, controlled study in Sri Lanka,
iron supplementation reduced morbidity in children
with and without an upper respiratory tract infection
[18]. There are studies suggesting that maternal anemia
during pregnancy is a risk factor for recurrent wheezing
[19]. Maternal anemia was not investigated in our study.
Reviewing the patients with recurrent hospitalizations
resulting from wheezing, we observed that the presence
of GER increased the risk of 3 or more hospitalizations
6.29 fold. In our study, 14 patients had been on GER
treatment, and 5 of the 14 had abnormal pH monitoring
results. The presence and treatment of GER has a sig-
nificant role in recurrent wheezing. A systematic review
of the clinical studies conducted between 1966 and 2008
revealed a mean GER prevalence of 20 % (ranging from
19.3 to 80 %) in children with asthma [20]. A study in-
vestigating the association between the recurrence of re-
spiratory symptoms and GER detected GER in 35 % of
the patients, which included 40 % of the enrolled cases
of reactive airway disease. In the same study, the respira-
tory complaints had started below the age of one in 86 %
of the patients with GER. A marked reduction in wheezing
was observed 3–6 months after anti-reflux treatment [21].
Empiric GER treatment would be an appropriate approach
in patients with recurrent hospitalizations resulting from
wheezing and in cases of no response or an inadequate re-
sponse to ICS treatment.
Patra et al. found that 42 % of the patients below the
age of 1 with wheezing had positive GER investigations.
They report that GER is a significant cause of recurrent
wheezing in patients below 2 years of age and recom-
mend GER investigations in patients with severe attacks
having an onset below the age of 1 year [22]. A trial by
Sheikh et al. detected silent chronic aspiration secondary
to difficulty of swallowing without GER in 13 infants
with chronic respiratory symptoms [23].
Consensus was not achieved on the description, assess-
ment and treatment of wheezing in pre-school children;
however, a trial of ICS and montelukast treatment in pa-
tients with recurrent wheezing, with discontinuation of
treatment in non-responders, was recommended [24].
In an observational study by Saglani et al., invasive
tests, including computed chest tomography, blood tests,
a nasal cilia biopsy, flexible bronchoscopy with broncho-
alveolar lavage, and pH monitoring, were performed in
47 patients, between 3 months and 5 years of age, who
experienced recurrent wheezing despite ICS treatment.
One-third of the patients had abnormal investigation re-
sults, and these patients were diagnosed with an airway
abnormality, GER, eosinophilic airway inflammation,
and bacterial infection [25]. In our study, 80 % of the pa-
tients had not received previous ICS treatment or were
not using the therapy regularly.
Regardless of the age at onset, atopic findings, trigger-
ing factors or the frequency of wheezing, the most com-
mon cause of recurrent wheezing is asthma [26]. A
study in Finland suggested that, based on a 6-month
follow-up, more than one-third of children below 2 years
of age, hospitalized for wheezing, were diagnosed with
asthma, and the risk was high, particularly in those with
recurrent wheezing and allergic findings [27].
Salbutamol syrup remains in use for the treatment of
wheezing. Whereas the Global Initiative for Asthma
(GINA) and National Asthma Education and Prevention
Program (NAEPP) consensus reports do not include sal-
butamol syrup in the treatment protocol for asthma for
patients below 5 years of age, the syrup is frequently
used in the treatment of wheezing [28–31]. Whereas sal-
butamol syrup should not be used because of the absence
of efficacy for the treatment of wheezing and the presence
of side effects, this treatment remains in use because of
economic reasons and the societal prejudice against in-
haled treatments [32]. Physicians have a great role in the
implantation of treatment protocols through efforts to in-
form society and establishing consensus reports.
Considering that the study was conducted in winter
and that one-half of the pulmonary radiography investiga-
tions were reported as increased ventilation and infiltra-
tion/atelectasis, the most likely cause of wheezing was
infection. We were unable to perform a respiratory viral
panel. There were 14 patients with GER findings (31.8 %),
and 5 patients (11.4 %) had esophageal pH monitoring re-
sults consistent with reflux. The sensitivity, specificity and
clinical utility of pH monitoring for extra esophageal indi-
cations are not well established.
The high serum IgE level, eosinophilia, inhalant/food
panel detected in 53 %, 14 %, and 10 % of the patients,
respectively, suggest the presence of changes secondary
to infection rather than an atopic background. An in-
creased serum IgE level might be associated with an
acute viral infection in atopic and non-atopic children
[33]. IgE production is secondary to an inflammatory
process occurring in the asthmatic airway rather than to
a specific allergen [34]. The presence of eosinophilia
might be explained by parasitosis as well as atopy. Of
the other tests requested, the immunoglobulin panel,
PPD, sweat test and ECHO investigation yielded normal
results in a larger portion of patients. The low frequency
of the diagnoses of immunodeficiency, cystic fibrosis and
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cardiac abnormality that should be considered in the dif-
ferential diagnosis of recurrent wheezing might be at-
tributed to the small number of patients. If the number
of the patients were larger, we could hypothesize that
the probability of diagnosing the above conditions would
increase.
The strength of our study is that it is the first to assess
the risk factors for 2 or more recurrent hospitalizations
resulting from wheezing. An important limitation of this
retrospective study results from missing data, incomplete
data, unknown confounders, and the small sample size.
Conclusion
Anemia and GER are risk factors for recurrent hospitaliza-
tions for wheezing and should be treated. In cases of re-
current wheezing, the investigations to be performed are
quite limited if the history and the physical examination
are not atypical. Various non-invasive and invasive investi-
gations are increasingly performed to rule out other po-
tential pathologies and as a measure against malpractice
claims. Most of these investigations are unnecessary and
expensive and lead to radiation and trauma to children. If
the physical examination and history are not abnormal, an
ICS trial should be administered, with further investiga-
tions planned for non-responders; this protocol would be
more appropriate than requesting investigations to rule
out potential diagnoses.
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